Literature DB >> 1851310

Inhibitory effect of ritanserin on the 5-hydroxytryptophan-mediated cortisol, ACTH and prolactin secretion in humans.

M A Lee1, J F Nash, M Barnes, H Y Meltzer.   

Abstract

Oral administration of the serotonin (5-HT) precursor L-5-hydroxytryptophan (5-HTP), 200 mg, significantly increased plasma cortisol levels in man. L-5-HTP had no significant effect on the plasma prolactin levels. A borderline effect of 5-HTP on plasma ACTH levels was found. Pretreatment with the 5-HT2/5-HT1c antagonist ritanserin (5 mg, PO, b.i.d. for 2 days) significantly inhibited 5-HTP-induced cortisol secretion. Ritanserin had no effect on the basal plasma cortisol or prolactin levels. These data are suggestive that 5-HTP stimulates cortisol secretion in man via 5-HT2/5-HT1c receptor mechanisms.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1851310     DOI: 10.1007/bf02244213

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  38 in total

1.  Stimulation of serum cortisol and prolactin secretion in humans by MK-212, a centrally active serotonin agonist.

Authors:  M T Lowy; H Y Meltzer
Journal:  Biol Psychiatry       Date:  1988-04-15       Impact factor: 13.382

2.  Endocrine responses to 5-hydroxytryptamine-1A receptor activation by ipsapirone in humans.

Authors:  K P Lesch; R Rupprecht; B Poten; U Müller; K Söhnle; J Fritze; H M Schulte
Journal:  Biol Psychiatry       Date:  1989-06       Impact factor: 13.382

3.  Effect of 1-5 hydroxytryptophan infusion on growth hormone and prolactin secretion in man.

Authors:  I Lancranjan; A Wirz-Justice; W Pühringer; E Del Pozo
Journal:  J Clin Endocrinol Metab       Date:  1977-09       Impact factor: 5.958

4.  Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humans.

Authors:  E A Mueller; D L Murphy; T Sunderland
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

5.  Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.

Authors:  J E Leysen; W Gommeren; P Van Gompel; J Wynants; P F Janssen; P M Laduron
Journal:  Mol Pharmacol       Date:  1985-06       Impact factor: 4.436

6.  Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects.

Authors:  G R Heninger; D S Charney; D E Sternberg
Journal:  Arch Gen Psychiatry       Date:  1984-04

7.  Central action of ipsapirone, a new anxiolytic drug, on serotoninergic, noradrenergic and dopaminergic functions.

Authors:  J Maj; E Chojnacka-Wójcik; E Tatarczyńska; A Kłodzińska
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

8.  Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. I. Enhanced response in depression and mania.

Authors:  H Y Meltzer; B Umberkoman-Wiita; A Robertson; B J Tricou; M Lowy; R Perline
Journal:  Arch Gen Psychiatry       Date:  1984-04

9.  Stimulation of corticosterone and beta-endorphin secretion in the rat by selective 5-HT receptor subtype activation.

Authors:  J I Koenig; G A Gudelsky; H Y Meltzer
Journal:  Eur J Pharmacol       Date:  1987-05-07       Impact factor: 4.432

10.  Rapid radioimmunoassay for corticotropin in unextracted human plasma.

Authors:  W E Nicholson; D R Davis; B J Sherrell; D N Orth
Journal:  Clin Chem       Date:  1984-02       Impact factor: 8.327

View more
  7 in total

1.  Ziprasidone decreases cortisol excretion in healthy subjects.

Authors:  Andreas Meier; Anna-Catharina Neumann; Wolfgang Jordan; Gerald Huether; Andrea Rodenbeck; Eckart Rüther; Stefan Cohrs
Journal:  Br J Clin Pharmacol       Date:  2005-09       Impact factor: 4.335

2.  Effect of pindolol on hormone secretion and body temperature: partial agonist effects.

Authors:  H Y Meltzer; M Maes
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

3.  5-HT2a/2c receptor blockade by amesergide fully attenuates prolactin response to d-fenfluramine challenge in physically healthy human subjects.

Authors:  E F Coccaro; R J Kavoussi; M Oakes; T B Cooper; R Hauger
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

4.  Effect of pindolol on the L-5-HTP-induced increase in plasma prolactin and cortisol concentrations in man.

Authors:  H Y Meltzer; M Maes
Journal:  Psychopharmacology (Berl)       Date:  1994-05       Impact factor: 4.530

5.  The metabolic fate of infused L-tryptophan in men: possible clinical implications of the accumulation of circulating tryptophan and tryptophan metabolites.

Authors:  G Heuther; G Hajak; A Reimer; B Poeggeler; M Blömer; A Rodenbeck; E Rüther
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

6.  Serotonergic function and late luteal phase dysphoric disorder.

Authors:  A T Veeninga; H G Westenberg
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  Effects of ritanserin, a novel serotonin-S2 receptor antagonist, on the secretion of pituitary hormones in normal humans.

Authors:  D Tepavcević; Z Giljević; M Korsić; S Halimi; E Suchanek; T Jelić; I Aganović; B Kozić; V Plavsić
Journal:  J Endocrinol Invest       Date:  1994-01       Impact factor: 4.256

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.